Streetbeat News

Partnerships

BCLI

PLUR

BrainStorm Cell Therapeutics has signed a Memorandum of Understanding with Pluri Inc. to manufacture NurOwn for a Phase 3b trial in ALS. This partnership will allow BrainStorm to transfer its manufacturing technology to Pluri's facility.

Portfolio Pulse from

November 11, 2024 | 11:15 am

QRVO

Cambridge GaN Devices (CGD) and Qorvo have partnered to develop the PAC5556A + ICeGaN® evaluation kit, combining motor control and power efficiency technologies.

Portfolio Pulse from

November 11, 2024 | 10:45 am

CAN

Canaan Inc. has signed a purchase agreement with HIVE Digital Technologies for its Avalon A1566 miners, marking a continued expansion in North America.

Portfolio Pulse from

November 11, 2024 | 9:30 am

NOK

Nokia partners with Fibertime to expand broadband access in South Africa, reaching underserved communities in 5 cities and 14 townships. This initiative uses Nokia's fiber solution to provide affordable internet to millions of low-income customers.

Portfolio Pulse from

November 11, 2024 | 8:15 am

ANPCY

AZN

ANGLE PLC's Parsortix system shows potential in improving treatment tracking and identifying drug-resistant cases in non-small cell lung cancer (NSCLC) by analyzing circulating tumor cells and DNA. The study involved patients treated with AstraZeneca's osimertinib.

Portfolio Pulse from

November 11, 2024 | 7:45 am

MSFT

AI start-ups are competing against tech giants like Microsoft and Google at Europe's largest technology conference, Web Summit, to attract investor interest.

Portfolio Pulse from

November 11, 2024 | 6:15 am

MSFT

Microsoft's $13 billion partnership with OpenAI highlights its ambitious AI strategy. Despite strong Q1 2025 earnings with a 16% revenue increase, Microsoft faces challenges in the search market. Heavy CAPEX investment in AI infrastructure positions it for future AI leadership.

Portfolio Pulse from

November 11, 2024 | 4:45 am

TSLY

YieldMax TSLA Option Income Strategy ETF (TSLY) has been upgraded to a hold due to potential benefits from Elon Musk's increased influence as an 'Efficiency Czar' following Trump's election win. This could boost Tesla's business, indirectly benefiting TSLY through increased volatility.

Portfolio Pulse from

November 11, 2024 | 4:45 am

GNNSF

GenScript Biotech Corporation has announced the establishment of a new operations site and logistics center in Sydney, Australia, enhancing its global presence in life sciences services and products.

Portfolio Pulse from

November 11, 2024 | 3:00 am

NVNXF

Novonix, an Australian battery maker, has signed a binding off-take agreement with Stellantis to supply synthetic graphite to Stellantis' cell manufacturing partners in North America.

Portfolio Pulse from

November 10, 2024 | 11:30 pm